Navigation Links
Swine Flu Vaccine Seems Safe: Experts
Date:9/4/2009

So far, trials show no problems and shot should be as safe as that for seasonal flu, officials say

FRIDAY, Sept. 4 (HealthDay News) -- Despite persistent public concern that H1N1 vaccines being tested might have unforeseen side effects, experts reiterated Thursday that so far, at least, the shots seem safe.

"There have been no red flags at all," Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, told HealthDay.

A trial designed to test the vaccine on healthy adults began on Aug. 7, while another trial involving children started Aug. 18.

"We wanted to wait about a week after the first trial to see if there were any glaring safety issues. There were not, so one-and-a-half weeks later, we started the trial in children," Fauci said.

And Fauci is optimistic that the vaccine will continue to be safe.

"It's unlikely there will be safety issues," he said. "We don't expect any because this vaccine is strikingly similar to the seasonal vaccine we give every year to millions and millions and millions of people."

Still, rare side effects will only come to light after millions of people have been vaccinated and after different population subgroups have been exposed to the vaccine.

"No clinical trial in the world is going to be large enough to be able to detect an event that occurs one in every 100,000 people," Fauci said. "The only way to pick that up is after the fact, when a lot of people get vaccinated and good surveillance picks it up."

Another expert agreed. "One of the challenges is that sometimes on the safety issue, only large-scale use will uncover rare events," said Dr. Melinda Moore, senior health researcher with the RAND Corporation in Arlington, Va., and a former epidemiologist with the U.S. Centers for Disease Control and Prevention. "That's not unique to this product. That's why there's so much after-market surveillance."

Such a surveillance system will be in place and operable when the first vaccinations start to roll out. Fauci anticipates that 45 million to 50 million doses will be available by Oct. 15.

Many people are painfully aware of a U.S. government decision in 1976 to vaccinate 43 million people against swine flu -- it backfired badly.

Not only did the dreaded outbreak never materialize, but some 500 Americans who did get vaccinated came down with a rare neurodegenerative condition called Guillain-Barre syndrome, which many experts believe was linked to the shot. Twenty-five of those 500 people died.

One thing that's already different about this year's H1N1 virus: The 1976 virus never spread beyond 240 soldiers stationed at Fort Dix, N.J., while the current outbreak has already sickened more than 200,000 people worldwide, killing 2,200 or more, according to the World Health Organization.

"That [1976] virus never evolved," Moore said. "People thought it was going to be a new pandemic. It didn't turn out to be. The threat wasn't as big as they thought. This virus has already demonstrated that it has spread."

Still, segments of the public may be wary of any vaccine they perceive as being rushed out too fast. A report in a recent issue of the BMJ found that more than half of all health-care workers surveyed in Hong Kong have already decided not to get vaccinated because of fears about safety and doubts on efficacy.

U.S. officials do not yet know whether the vaccine will require one or two doses. "We will know in a week or so if one dose is going to be enough," Fauci said. "We're hoping it's going to be one."

Reports published Thursday by drug maker Novartis suggest its vaccine may be effective after just one jab.

If two doses are needed, researchers will need to figure out how far apart they should be given, Moore said, and whether an adjuvant -- something to boost the immune response -- is called for.

"They will have to balance it all out," she said. "Ultimately the product needs to be licensed. This is not a theoretical exercise. The virus is here and so is the U.S. population -- and so is the flu season."

More information

Find out more about the H1N1 swine flu at the U.S. Centers for Disease Control and Prevention.



SOURCES: Anthony Fauci, M.D., director, U.S. National Institute of Allergy and Infectious Diseases; Melinda Moore, M.D., senior health researcher, RAND Corporation, Arlington, Va.


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Swine flu monitoring needed for farm workers, study says
2. eFoodSafety Enters Research Agreement with University of Minnesota to Test New Food-Grade Antiviral for Swine Influenza Virus
3. Swine Flu Cases Now Total 7: CDC
4. At Least 16 Dead, Hundreds Ill in Swine Flu Outbreak in Mexico
5. At Least 20 Dead, Hundreds Ill in Swine Flu Outbreak in Mexico
6. International SOS Releases Web Site to Educate Public About Swine Flu Outbreak
7. WHO Warns of Possible Pandemic as Mexico Seeks to Contain Swine Flu
8. U.S. Declares Public Health Emergency in Response to Swine Flu
9. Obama Says Swine Flu Outbreak No Cause for Alarm
10. Pennsylvania Working Closely With Federal Partners to Contain Impact of Swine Flu
11. Swine Flu: Infection Control in Hospitals Will Be Critical
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Swine Flu Vaccine Seems Safe: Experts
(Date:12/6/2016)... ... 06, 2016 , ... The Behavioral Health Center of Excellence ... organization as a top behavioral service provider in the country. The award celebrates ... satisfaction and qualifications, and consumer satisfaction. These areas are measured via a wide-ranging ...
(Date:12/6/2016)... ... December 06, 2016 , ... Experimentation involving human stem ... largely due to its potential for revolutionizing human disease treatment. There are multiple ... pluripotent stem cells (hiPSCs). , Both platforms have distinct advantages and disadvantages, ...
(Date:12/6/2016)... ... 06, 2016 , ... METTLER TOLEDO has launched its online ... white papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, brochures, datasheets, user ... documents, webinars and videos available online, visit the METTLER TOLEDO Expertise Library ...
(Date:12/6/2016)... ... ... 'Tis the season for family, festivity, food and fun! Temptation abounds, and ... eating healthy, staying active, and taking medication and doing daily foot health checks (a ... "Shopping trips, parties and family gatherings can take their toll on our feet during ...
(Date:12/6/2016)... B.C., Canada (PRWEB) , ... December 06, 2016 ... ... (STC) announce the availability of the newly updated International Audit Protocol Consortium (IAPC) ... use IAPC EHS audit protocols to understand the scope of their EHS regulatory ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Nov. 29, 2016 Several leading Alzheimer,s ... Accera, Inc. at 11 a.m. EST on ... Conference on Clinical Trials for Alzheimer,s Disease (CTAD). The ... in Alzheimer,s disease and therapeutic targets that address deficient ... "Following the recent failure of another therapy targeting the ...
(Date:12/5/2016)... , Dec 5, 2016 Research ... Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease ... - Global Forecasts to 2021" report to their offering. ... , , ... USD 730.7 Million in 2021 from USD 574.8 Million in 2016, ...
(Date:12/5/2016)... PUNE, India , December 5, 2016 ... Market by Product Type and by Application - Global Opportunity Analysis and Industry ... in 2015, and is expected to reach $5,255 million by 2022, growing at ... market in 2015 with more than four-fifths share. ... ...
Breaking Medicine Technology: